A blood-based algorithm for the detection of Alzheimer's disease (Q35203409)

7 August 2017

A blood-based algorithm for the detection of Alzheimer's disease (English)

1 reference

7 August 2017

0 references

Sid E O'Bryant

1

0 references

Ramon Diaz-Arrastia

object named as

Ramon Diaz-Arrastia

11

0 references

Kirk Wilhelmsen

10

object named as

Kirk Wilhelmsen

1 reference

7 August 2017

Guanghua Xiao

2

1 reference

7 August 2017

Robert Barber

3

1 reference

7 August 2017

Joan Reisch

4

1 reference

7 August 2017

James Hall

5

1 reference

7 August 2017

C Munro Cullum

6

1 reference

7 August 2017

Rachelle Doody

7

1 reference

7 August 2017

Thomas Fairchild

8

1 reference

7 August 2017

Perrie Adams

9

1 reference

7 August 2017

Texas Alzheimer’s Research and Care Consortium

12

1 reference

7 August 2017

24 August 2011

1 reference

Dementia and Geriatric Cognitive Disorders

7 August 2017

1 reference

7 August 2017

32

1 reference

7 August 2017

1

1 reference

7 August 2017

55-62

1 reference

Multimodal classification of Alzheimer's disease and mild cognitive impairment

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

A serum protein-based algorithm for the detection of Alzheimer disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Role of vascular risk factors and vascular dysfunction in Alzheimer's disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Decreased C-reactive protein levels in Alzheimer disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Biological marker candidates of Alzheimer's disease in blood, plasma, and serum.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Brain-derived neurotrophic factor levels in Alzheimer's disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

2008 Alzheimer's disease facts and figures

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

A profile of impaired insulin degradation in relation to late-life cognitive decline: a preliminary investigation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

The role of biomarkers in clinical trials for Alzheimer disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

The Clinical Dementia Rating (CDR): current version and scoring rules

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Development and validation of a geriatric depression screening scale: a preliminary report

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

13 July 2018

1 reference

An examination of the Boston Naming Test: calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population

21 January 2018

1 reference

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

21 January 2018

1 reference

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

21 January 2018

1 reference

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

21 January 2018

1 reference

Estimating the predictive value of the Test of Memory Malingering: an illustrative example for clinicians.

21 January 2018

1 reference

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

21 January 2018

1 reference

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.

21 January 2018

1 reference

A novel blood test for the early detection of Alzheimer's disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

A gene expression pattern in blood for the early detection of Alzheimer's disease.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169374

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

26 September 2018

1 reference

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21865746

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1159/000330750

1 reference

7 August 2017

1 reference

7 August 2017

1 reference